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Summary. Trial-based economic evaluations are typically performed on cross-sectional
variables, derived from the responses for only the completers in the study, using
methods that ignore the complexities of utility and cost data (e.g. skewness and
spikes). We present an alternative and more efficient Bayesian parametric approach
to handle missing longitudinal outcomes in economic evaluations, while accounting
for the complexities of the data. We specify a flexible parametric model for the ob-
served data and partially identify the distribution of the missing data with partial iden-
tifying restrictions and sensitivity parameters. We explore alternative nonignorable
scenarios through different priors for the sensitivity parameters, calibrated on the ob-
served data. Our approach is motivated by, and applied to, data from a trial assessing
the cost-effectiveness of a new treatment for intellectual disability and challenging be-
haviour.
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1. Introduction
Economic evaluation alongside Randomised Clinical Trials (RCTs) is an important
and increasingly popular component of the process of technology appraisal (NICE,
2013). The typical analysis of individual level data involves the comparison of two
interventions for which suitable measures of clinical benefits and costs are observed
on each patient enrolled in the trial at different time points throughout the follow up.
Typically, clinical benefits are measured through multi-attribute utility instru-
ments (e.g. the EQ-5D-3L: http://www.euroqol.org), costs are obtained from clinic
resource records and both are summarised into cross-sectional quantities, e.g. Qual-
ity Adjusted Life Years (QALYs). The main objective of the economic analysis is a)
to combine the population average clinical benefits (or effectiveness) and costs in or-
der to determine the most “cost-effective” intervention, given current evidence; and
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b) to assess the impact of the uncertainty in the model inputs on the decision-making
process (Claxton, 1999; Briggs, 2000; Spiegelhalter et al., 2004; OHagan et al., 2004;
Sculpher et al., 2005; Briggs et al., 2006; Jackson et al., 2009; Baio, 2012).
Individual level data from RCTs are almost invariably affected by missingness.
The recorded outcome process is often incomplete due to individuals who drop out
or are observed intermittently throughout the study, causing some observations to
be missing. In most applications, the economic evaluation is performed on the
cross-sectional variables, computed using only the data from the individuals who
are observed at each time point in the trial (completers), with at most limited
sensitivity analysis to missingness assumptions (Noble et al., 2012; Gabrio et al.,
2017; Leurent et al., 2018). This, however, is an extremely inefficient approach as
the information from the responses of all partially observed subjects is completely
lost and it is also likely biased unless the completers are a random sample of the
subjects on each arm (Little and Rubin, 2002).
Handling missingness can be very challenging, especially because missing obser-
vations may themselves provide information about the distribution of the unobserved
data (Rubin, 1987; Little and Rubin, 2002). Dealing with informative missingness
is not straightforward as inference can be drawn only under untestable assumptions
about the unobserved data and is often sensitive to the particular assumptions made
(Molenberghs et al., 1997). It is therefore desirable to assess the robustness of the
inference by varying these assumptions in a principled way (Scharfstein et al., 1999;
Vansteelandt et al., 2006; Daniels and Hogan, 2008).
The problem of informative missingness is often embedded within a more com-
plex framework, which makes the modelling task in economic evaluations particularly
challenging. Specifically, the effectiveness and cost data typically present a series
of complexities that need to be simultaneously addressed to avoid biased results.
First, the presence of a bivariate outcome requires the use of appropriate methods
that deal with correlation (O’Hagan and Stevens, 2001). Second, outcome data
typically have empirical distributions that are highly skewed. The adoption of para-
metric distributions that can account for skewness (e.g. Beta for the utilities and
Gamma or Log-Normal for the costs) has been suggested to improve the fit (Nixon
and Thompson, 2005; Thompson and Nixon, 2005). In addition, data may exhibit
spikes at one or both of the boundaries of the range for the underlying distribu-
tion that may induce high skewness in the data that is difficult to capture using
standard parametric models (Cooper et al., 2003). For example, some patients in
a trial may not accrue any cost at all or some individuals may be associated with
perfect health, i.e. unit QALY. The use of more flexible formulations, known as
hurdle models, explicitly accounts for these “structural” values. Hurdle models are
essentially a mixture between a point mass distribution (the spike) and a parametric
model fit to the natural range of the relevant variable without the boundary values.
Hurdle models have been applied in economic evaluations for handling either costs
or QALYs (Baio, 2014; Gabrio et al., 2018).
Using a recent randomised trial as our motivating example, we present a Bayesian
parametric model for conducting inference on a bivariate health economic longitudi-
nal response. We specify our model to account for the different types of complexities
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affecting the data while accommodating a sensitivity analysis to explore the impact
of alternative missingness assumptions on the inferences and on the decision-making
process for health technology assessment.
1.1. Positive Behaviour Support Trial
The Positive Behaviour Support (PBS) study (Hassiotis et al., 2018) is a multicenter
randomised controlled trial that, among its objectives, aimed to evaluate the cost-
effectiveness of a new multicomponent intervention (PBS, 108 subjects) relative
to treatment as usual (TAU, 136 subjects) for individuals suffering from mild to
severe intellectual disability and challenging behaviour. The primary instruments
used to assess the clinical benefits and costs were the EQ-5D-3L questionnaires and
family/paid carer clinic records, respectively. Utilities are derived from the health
questionnaires using the time trade-off algorithm (NICE, 2013) and are defined on
the interval [−0.594, 1], where 1 represents the perfect health state while negative
values indicate states that are considered “worse than death”. Costs, expressed in £,
are obtained from the clinic records. Subjects associated with either or both a
utility of one and a null cost are observed throughout the study. Measurements
were scheduled to be collected at baseline and at 6 and 12 months after baseline.
Let ui = (ui0, . . . , uiJ) and ci = (ci0, . . . , ciJ) denote the vectors of utilities
and costs that were supposed to be observed for subject i at time j in the study,
with j ∈ {0, 1, J = 2}. We denote with yij = (uij , cij) the bivariate outcome for
subject i formed by the utility and cost pair at time j. Both outcomes were partially
observed and missingness was nonmonotone in the sense that if yij was unobserved
then yij+1 could be either observed or unobserved. We group the individuals accord-
ing to the missingness patterns and denote with rij = (ruij , r
c
ij) a pair of indicator
variables that take value 1 if the corresponding outcome for subject i at time j is
observed and 0 otherwise. We denote with ri = (ri0; ri1; ri2) the missingness pattern
to which subject i belongs, where each pattern is associated with different values for
rij . For example, the pattern r = 1 is associated with the set r = (1, 1; 1, 1; 1, 1)
and corresponds to the completers pattern. We denote with Rt the total number
of observed patterns either in the control (R1 = 5) or intervention (R2 = 9) group.
Table 1 reports the missingness patterns in each treatment group as well as the
number of individuals and the observed mean responses within each pattern.
TABLE 1 HERE
The number of observed patterns is relatively small and with the exception of the
completers (r = 1) the patterns are quite sparse. Baseline costs in both treatment
groups are the only fully observed variables, while the average proportion of missing
utilities and costs is respectively 21% and 10% for the control (t = 1) and 10% and
8% for the intervention (t = 2).
1.2. Standard Approach to Economic Evaluation
To perform the economic evaluation, aggregated measures for both utilities and costs
are typically derived from the longitudinal responses recorded in the study. QALYs
4 A. Gabrio, MJ. Daniels and G. Baio
(eit) and total costs (cit) measures are computed as:
eit =
J∑
j=1
(uijt + uij−1t)
δj
2
and cit =
J∑
j=1
cijt, (1)
where δj =
Timej−Timej−1
Unit of time is the fraction of the time unit (12 months, in the PBS
study) between consecutive measurements. The economic evaluation is then carried
out by applying some parametric model p(eit, cit | θ) to these cross-sectional quanti-
ties, typically using linear regression methods to account for the imbalance in some
baseline variables between treatments (Manca et al., 2005; Van Asselt et al., 2009;
European Medicines Agency, 2013). Finally, QALYs and total costs population
mean values are derived from the model:
µet = E (eit | θ) and µct = E (cit | θ) . (2)
The quantities µet and µct represent the target of interest in each treatment group
t and are used in assessing the relative cost-effectiveness of the interventions.
In the original economic evaluation of the PBS study, the quantities in Equation 1
were derived based on the longitudinal responses for only the completers, while
discarding all other partially observed data. Next, the quantities in Equation 2 were
obtained under a frequentist approach in which the two outcome variables (eit, cit)
were modelled independently assuming normality for the underlying distributions
and using linear regression methods to control for differences in baseline values.
The modelling approach used in the original analysis has the limitation that µet
and µct are derived based only on the completers in the study and does not assess
the robustness of the results to a range of plausible missingness assumptions. The
model also fails to account for the different complexities that affect the utility and
cost data in the trial: from the correlation between variables to the skewness and
the presence of structural values (zero for the costs and one for the utilities) in
both outcomes.
1.3. A Longitudinal Model to Deal with Missingness
We propose an alternative, more efficient and less biased approach to deal with a
missing bivariate outcome in economic evaluations while simultaneously allowing for
the different complexities that typically affect utility and cost data. Our approach
includes a longitudinal model that improves the current practice by taking into
account the information from all observed data as well as the time dependence
between the responses. The targeted quantities can then be obtained by applying the
same formulae in Equation 1 to the marginal means at each time for yij = (uij , cij),
which can be easily derived from the model. This can be accomplished through
the specification of a joint distribution p(y, r | ω) for the response and missingness
pattern, where ω is some relevant parameter vector.
We define the data as y = (yobs,ymis) to indicate the subsets that are observed
and missing. Next, define p(y | θ) as the response model, parameterised by θ, and
p(r | y,ψ) as the missingness model, with parameters ψ. Missingness is said to
A Longitudinal Model to Handle Missingness in Economic Evaluations 5
be ignorable if the following three conditions hold (Little and Rubin, 2002): (1)
p(r | y,ψ) = p(r | yobs,ψ), that is, missingness depends only on the observed
responses, a condition known as Missing At Random (MAR); (2) the parameter
ω of the joint model p(y, r | ω) can be decomposed as (θ,ψ), with p(y | θ) and
p(r | y,ψ); (3) the parameters of the response and missingness model are a priori
independent, that is p(ω) = p(θ)p(ψ).
When any of these conditions is not satisfied, missingness is said to be non-
ignorable. Often, this is due to the failure of the first condition, which implies
p(r | yobs,ymis,ψ) 6= p(r | yobs,y′misψ) for ymis 6= y′mis, known as Missing Not At
Random (MNAR). In this case, the joint model p(y, r) will require untestable as-
sumptions about the missing data in order to be identified. We specify our nonignor-
able modelling strategy using the extrapolation factorisation and a pattern-mixture
approach with identifying restrictions (Little, 1994; Linero and Daniels, 2018).
In this work we present a parametric model with a fully Bayesian framework
that can account for both skewness and structural values within a partially-observed
outcomes setting. A major advantage of adopting a Bayesian approach is the ability
to allow for the formal incorporation of external evidence into the analysis through
the use of informative prior distributions. This is a crucial element for conducting
sensitivity analysis to assess the robustness of the results to a range of plausible
missing data assumptions.
1.4. Outline
In Section 2 we describe the general strategy used to define the model and the fac-
torisation chosen to specify the joint distribution of the cost and utility data and the
missingness patterns. In Section 3 we introduce the parametric model implemented
for the distribution of the observed data and present alternative specifications to
identify the joint model under nonignorability. In Section 4 we introduce the iden-
tifying restrictions used and the approach followed to conduct sensitivity analysis.
In Section 5 we implement our model to draw inferences on the PBS study under
alternative missingness assumptions. In Section 6 we summarise the results under
each scenario from a decision-maker perspective and compare the implications in
terms of cost-effectiveness. We close in Section 7 with a discussion.
2. Modelling Framework
We define our modelling strategy following Linero and Daniels (2015) and factor the
joint distribution for the response and missingness as:
p(y, r | ω) = p(yrobs, r | ω)p(yrmis | yrobs, r,ω)
where yrobs and y
r
mis indicate the observed and missing responses within pattern
r, respectively. This is the extrapolation factorisation and factors the joint into
two components, of which the extrapolation distribution p(yrmis | yrobs, r,ω) re-
mains unidentified by the data in the absence of unverifiable assumptions about
the full data (Daniels and Hogan, 2008). To specify the observed data distribution
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p(yrobs, r | ω) we use a working model p? for the joint distribution of the response
and missingness (Linero and Daniels, 2015).
p(yrobs, r | ω) =
∫
p?(y, r | ω)dymis
Since we use p?(y, r | ω) only to obtain a model for p(yrobs, r | ω) and not as a
basis for inference, the extrapolation distribution is left unidentified. Any inference
depending on the observed data distribution may be obtained using the working
model as the true model, with the advantage that it is often easier to specify a model
for the the full data p(y, r) compared with a model for the observed data p(yrobs, r).
We specify p∗ using a pattern mixture approach, factoring the joint p(y, r | ω) as
the product between the marginal distribution of the missingness patterns p(r | ψ)
and the distribution of the response conditional on the patterns p(y | r,θ), re-
spectively indexed by the distinct parameter vectors ψ and θ. If missingness is
monotone it is possible to summarise the patterns by dropout time and directly
model the dropout process (Daniels and Hogan, 2008; Gaskins et al., 2016). Un-
fortunately, as it often occurs in trial-based health economic data, missingness in
the PBS study is mostly nonmonotone and the sparsity of the data in most pat-
terns makes it infeasible to fit the response model within each pattern, with the
exception of the completers (r = 1). Thus, we decided to collapse together all the
non-completers patterns (r 6= 1) and fit the model separately to this aggregated
pattern and to the completers. The model can be represented as:
p(y, r | ω) = p(r | ψ) [p(y | r = 1,λ)]I{r=1}∏
r≥2
p(yrobs | r,η)
I{r 6=1}
 observed data distribution
∏
r≥2
p (yrmis | yrobs, r, ξ)
I{r 6=1} extrapolation distribution
where ω = (θ,ψ), λ and η are the distinct subsets of θ that index the response model
in the completers and non-completers patterns, and ξ is the subset of η that indexes
the extrapolation distribution. The joint distribution has three components. The
first is given by the model for the patterns and the model for the completers (r = 1),
where no missingness occurs. The second component is a model for the observed
data in the collapsed patterns r 6= 1 that, together with the first component, form
the observed data distribution. The last component is the extrapolation distribution.
Because the targeted quantities of interest (Equation 2) can be derived based on
the marginal utility and cost means at each time j, in our analysis we do not require
the full identification of p(yrmis | yrobs, r, ξ). Instead, we only partially identify the
extrapolation distribution using partial identifying restrictions (Linero and Daniels,
2018). Specifically, we only require the identification of the marginal means for the
missing responses in each pattern.
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Let Ir be the indices of the missing observations in pattern r and let J r′r ⊆ Ir
be the subset of the indices in Ir for which there are observed responses in r′. We
denote with yrmis = y
r(Ir), the missing responses in pattern r. Next, we denote
with yr′obs(J r
′
r ) ⊆ yr
′
obs the subset of the observed responses in r
′ that corresponds
to yrmis.
We identify the marginal mean of yrmis using the observed values y
r′
obs(J r
′
r ),
averaged across r′ 6= 1, and some sensitivity parameters ∆ = (∆u,∆c). Therefore,
we compute the marginal means by averaging only across the observed components
in pattern r′ and ignore the components that are missing.
E [yrmis | r] = E
[
E
r′ 6=1,J r′r
[
yr
′
obs(J r
′
r ) + ∆ | r′
]]
.
Alternative identifying restrictions for nonmonotone missing data are reviewed in
Linero and Daniels (2018). We start by setting a benchmark assumption with ∆ =
0, and then explore the sensitivity of the results to alternative scenarios by using
different prior distributions on ∆, calibrated on the observed data. Once the working
model has been fitted to the observed data and the extrapolation distribution has
been identified, the overall marginal mean for the response model can be computed
by marginalising over r, i.e. E [Y ] =
∑
r p(r)E [Y | r].
3. Model for the missingness patterns and observed response
The distribution of the number of patterns is a multinomial on {1, . . . , Rt}, with
the total number of patterns Rt and the probabilities ψrt conditional on the treat-
ment assignment t. We specify a prior for ψrt that gives more weight on the com-
pleters pattern and equal weights to the other patterns. Specifically, we choose
a Dirichlet(1− x, xR? , . . . , xR? ) prior, where x is the expected total dropout rate and
R? = 64 is the total number of potential patterns in the study. This is consistent
with the design of the study, where the experimenter expects at least (1 − x)% of
the individuals to provide complete data, i.e. to fall in r = 1. In practice, this prior
is not likely to affect the results as the amount of observed data is enough to learn
the posterior of ψrt . For comparison purposes, we also consider another specifica-
tion based on a noninformative Dirichlet(1, . . . , 1) prior for ψrt . Posterior results are
robust to the alternative prior choices.
The distribution of the observed responses yijt = (uijt, cijt) is specified in terms
of a series of conditional distributions that capture the dependence between utilities
and costs as well as the time dependence. We now drop the treatment indicator
t for clarity. To account for the skewness we use Beta and Log-Normal distribu-
tions for the utilities and costs, respectively. Since the Beta distribution does not
allow for negative values, we scaled the utilities on [0, 1] through the transformation
u?ij =
uij−min(uj)
max(uj)−min(uj) , and fit the model to these transformed variables. To ease the
notation we refer to these quantities simply as uij .
To account for the structural values uij = 1 and cij = 0 we use a hurdle approach
by including in the model the indicator variables duij := I(uij = 1) and dcij := I(cij =
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0), which take value 1 if subject i is associated with a structural value at time j and
0 otherwise. The probabilities of observing these values, as well as the mean of each
variable, are then modelled conditionally on the utilities and costs at the current
and previous times via linear regressions defined on the logit or log scale. The model
can be summarised as follows (for simplicity we omit the subject index i).
At time j = 0, we model the nonzero costs c0 6= 0 and the indicator dc0 := I(c0 =
0) as:
c0 | dc0 = 0 ∼ LogNormal (νc0, τ c0)
dc0 ∼ Bernoulli(pic0)
where νc0 and τ
c
0 are the mean and standard deviation for c0 given c0 6= 0 on the log
scale, while pic0 is the probability of a zero cost value. We next model the utilities
and the indicator du0 := I(u0 = 1) conditionally on the costs at the same time:
u0 | du0 = 0, c0 ∼ Beta (νu0 , σu0 )
logit(νu0 ) = α00 + α10 log c0
du0 | c0 ∼ Bernoulli(piu0 )
logit(piu0 ) = γ00 + γ10 log c0
where νu0 and σ
u
0 are the mean and standard deviation for u0 given u0 6= 1 and c0,
while piu0 is the probability of having a utility value of one given c0. We use logistic
transformations to define a linear dependence for p(u0 | c0, u0 6= 1) and include the
costs on the log scale to improve the fit of the model.
At time j = 1, 2, we extend the approach illustrated for j = 0, and make a
first-order Markov assumption. For the costs we have:
cj | dcj = 0, cj−1, uj−1 ∼ LogNormal
(
νcj , τ
c
j
)
νcj = β0j + β1j log cj−1 + β2juj−1
dcj | cj−1, uj−1 ∼ Bernoulli(picj)
logit(picj) = ζ0j + ζ1j log cj−1 + ζ2juj−1.
Similarly to time j = 0, the mean, standard deviation and probability parameters for
the costs at time j are indicated with νcj , τ
c
j and pi
c
j . The regression parameters βj =
(β0j , β1j , β2j) and ζj = (ζ0j , ζ1j , ζ2j) capture the dependence between costs at j and
the costs and utilities at j − 1, for the non-zero and zero components, respectively.
The model for the utilities is:
uj | duj = 0, cj , uj−1 ∼ Beta
(
νuj , σ
u
j
)
logit(νuj ) = α0j + α1j log cj + α2juj−1
duj | cj , uj−1 ∼ Bernoulli(piuj )
logit(piuj ) = γ0j + γ1j log cj + γ2juj−1.
We denote with νuj , σ
u
j and pi
u
j the mean, standard deviation and probability param-
eters for the utilities at time j, and with αj = (α0j , α1j , α2j) and γj = (γ0j , γ1j , γ2j)
A Longitudinal Model to Handle Missingness in Economic Evaluations 9
the regression parameters that capture the dependence between utilities at j and
costs at j and utilities at j − 1.
For all parameters in the model we specify vague prior distributions. Specifically
a Normal with a large variance on the appropriate scale for the regression parameters
and Uniform over a large positive range for the standard deviations. We implement
the model and derive the marginal cost and utility means at each time j through
Monte Carlo Integration. First, we fit the model separately to the completers (r = 1)
and the joint set of all other patterns (r 6= 1) for t = 1, 2. Second, at each iteration of
the posterior distribution, we generate a large number of samples for yij = (cij , uij)
based on the posterior values for the parameters of the utility and cost models
in the MCMC output. Third, we approximate the posterior distribution of the
marginal means for each r by taking the expectation over these sampled values at
each iteration. Finally, we derive the overall marginal means µjt = (µcjt, µ
u
jt) as
weighted averages across the marginal means in each pattern, using the posterior
ψrt as weights.
4. Identifying Restrictions and Sensitivity Parameters
Identifying restrictions provide a convenient approach to identify the extrapolation
distribution and conduct sensitivity analysis. In short, identifying restrictions cor-
respond to assumptions about p(y, r), which link the observed data distribution
p(yobs, r) to the extrapolation distribution p(ymis | yobs, r). It can be useful to
specify a single identifying restriction as a benchmark assumption and consider in-
terpretable deviations from that benchmark to assess how inferences are driven by
our assumptions (Linero and Daniels, 2018). As mentioned in Section 2, we con-
sider partial restrictions that do not fully identify the joint p(y, r) but, in our setting,
allow us to identify the posterior distribution of the marginal means.
Sensitivity parameters (∆) are often embedded within identifying restrictions to
assess the impact of alternative missingness assumptions on the quantities of interest.
We choose ∆j = (∆cj ,∆
u
j ) to be time-specific location shifts at the marginal mean
in each pattern (Daniels and Hogan, 2000). Specifically, we identify the marginal
mean of the missing responses in each pattern yrmis by averaging across the corre-
sponding components that are observed yr′obs(J r
′
r ) for r′ 6= 1 and add the sensitivity
parameters ∆j .
E [yrmis | r] = E
[
E
r′ 6=1,J r′r
[
yr
′
obs(J r
′
r ) + ∆j | r′
]]
,
for j ∈ {0, 1, 2}. As a reasonable benchmark assumption we set ∆j = 0. We then
explore departures from this benchmark based on the assumption that subjects with
a missing value at time j are more likely to have a lower utility and a higher cost
compared with those who are observed at the same time but were not a completer.
We calibrate the priors on ∆j using the observed standard deviations for costs and
utilities at each time j to define the amplitude of the departures from ∆j = 0.
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5. Application to the PBS Study
5.1. Computation
We fitted the model using JAGS, (Plummer, 2010), a software specifically designed
for the analysis of Bayesian models using Markov Chain Monte Carlo (MCMC)
simulation (Brooks et al., 2011), which can be interfaced with R through the package
R2jags (Su and Yajima, 2015). Samples from the posterior distribution of the
parameters of interest generated by JAGS and saved to the R workspace are then used
to produce summary statistics and plots. We ran two chains with 20,000 iterations
per chain, using a burn-in of 5,000, for a total sample of 30,000 iterations for posterior
inference. For each unknown quantity in the model, we assessed convergence and
autocorrelation of the MCMC simulations using diagnostic measures including the
potential scale reduction factor and the effective sample size (Gelman et al., 2004).
In the non-completers pattern (r 6= 1), we set to 0 the regression parameters
(ζ11,ζ21) and (γ10,γ11,γ21) for the model fitted to the control and intervention group,
respectively. This simplification was required because, among the non-completers,
there is only one observed cj = 0 at time j = 1 in the control group and one observed
uj = 1 at time j = {0, 1} in the intervention group. We therefore drop from the
model the dependence between the probabilities of having a structural value at these
times and the variables at the previous or same times to ensure the convergence of
the algorithm and avoid identifiability problems.
5.2. Model Assessment
We computed the Deviance Information Criterion (DIC; Spiegelhalter et al., 2002)
to assess the fit of the model with respect to an alternative parametric specification,
where the LogNormal distributions are replaced with Gamma distributions for the
cost variables. The DIC is a measure of comparative predictive ability based on the
model deviance and a penalty for model complexity known as effective number of
parameters (pD). When comparing a set of models based on the same data, the
one associated with the lowest DIC is the best-performing, among those assessed.
There are different ways of constructing the DIC in the presence of missing data,
which means that its use and interpretation are not straightforward (Celeux et al.,
2006; Daniels and Hogan, 2008; Mason et al., 2012). In our analysis, we consider a
DIC based on the observed data under MAR as its value does not depend on the
values of the sensitivity parameters (Wang and Daniels, 2011). Because the sampling
distribution of the observed data was not available in closed form, we computed it
using Monte Carlo integration. Results between the two alternative specifications
are reported in Table 2.
TABLE 2 HERE
The DIC components for the costs are systematically lower when LogNormal distri-
butions are used compared with Gamma distributions (lower values shown in italics
in Table 2), and result in an overall better fit to the data for the first model.
We also assess the absolute fit of the model using posterior predictive checks
based on observed data replications (Xu et al., 2016). We sample from the posterior
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predictive distribution p(y˜, r˜ | yrobs, r,ω). Conditional on the replicated patterns r˜,
we define the replicated observed data in each pattern as y˜r˜obs = {y˜j : r˜j = 1}, that
is the components of y˜ for which the corresponding missing data indicators at time j
in the replicated patterns r˜ are equal to one.
We compute the rank correlations between each pair of variables for each repli-
cated dataset, and compare them with the corresponding values from the real
dataset. The results, shown in Figure 1, suggest that the proposed parametric model
captures most of the correlations well both in the control (panel a) and intervention
(panel b) group.
FIGURE 1 HERE
5.3. Priors on Sensitivity Parameters
We consider three alternative sets of priors on ∆j = (∆uj ,∆
c
j), calibrated based on
the variability in the observed data at each time j. The three types of priors used
are the following:
• ∆flat: Flat between 0 and twice the observed standard deviation:
∆cj ∼ Uniform[0, 2 sd(cj)] and ∆uj ∼ Uniform[−2 sd(uj), 0]
• ∆skew0: Skewed towards values closer to 0, over the same range as ∆flat:
∆cj = 2 sd(cj)
(
1−
√
Uniform[0, 1]
)
and ∆uj = −2 sd(uj)
(
1−
√
Uniform[0, 1]
)
• ∆skew1: Skewed towards values far from 0, over the same range as ∆flat:
∆cj = 2 sd(cj)
(√
Uniform[0, 1]
)
and ∆uj = −2 sd(uj)
(√
Uniform[0, 1]
)
where sd(uj) and sd(cj) are the standard deviations computed on the observed
utilities and costs at time j for r 6= 1. We choose these priors because we believe
that departures from ∆j = 0 for both outcomes are not likely to be larger than
twice the observed standard deviations at each time j.
5.4. Results
Figure 2 compares the posterior means and 95% highest posterior density (HPD)
credible intervals for µjt = (µujt, µ
c
jt) obtained from fitting the model under six
alternative scenarios: completers (CC), all cases assuming ignorability (MAR), and
using the extrapolation factorisation under the benchmark (∆j = 0) and three
departure scenarios (∆flat,∆skew0,∆skew1). Since baseline costs are fully observed,
only the estimates under CC and MAR are shown for µc0. Results associated with
the control and intervention group are indicated in red and blue, respectively.
FIGURE 2 HERE
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The distributions of both µuj and µ
c
j show values that are higher in the intervention
compared with the control at each time j, and are similar across CC, MAR and
∆ = 0. However, under the other nonignorable scenarios, mean utilities/costs are
on average 3% (∆flat), 4% (∆skew0) and 5% (∆skew1) lower/higher compared with
∆ = 0 in the control group. In the intervention group, mean utilities/costs are
on average 1% (∆flat), 1.5% (∆skew0) and 2.5% (∆skew1) lower/higher compared
with ∆ = 0.
We then derived the QALYs and total costs means µet and µct by applying the
formulae in Equation 1 to the cost and utility marginal means µjt obtained from
the model. We also compare the estimates derived from our approach with those
obtained from a cross-sectional model fitted on ei and ci, computed only based on the
completers in the study, as a standard approach used in trial-based analyses (CS).
This model was specified following the approach used in the original analysis of the
PBS study (assuming bivariate normality and including baseline adjustments), but
implemented within a Bayesian framework.
Table 3 shows the posterior means and 95% HPD credible intervals associated
with the targeted quantities under all scenarios for both treatment groups.
TABLE 3
Results under CS are systematically lower for both mean parameters with respect
to those from any other scenario. Compared with CC, we respectively observe a
decrease of 38% and 21% in the control and intervention group for µet and of 10%
and 5% for µct.
Across the other scenarios, variations of similar amplitude and with the same sign
to those for µjt affect the QALYs and total cost mean estimates. In the control,
compared with ∆ = 0, mean QALYs and total costs show decrements between 2.8%
and 5.7% and increments between 3.5% and 7% with respect to the three nonig-
norable scenarios, respectively. In the intervention, the corresponding decreases in
mean QALYs are between 1% and 2% while the increases in mean total costs are
between 1.2% and 2.3% .
6. Economic Evaluation
We complete the analysis by assessing the cost-effectiveness of the new interven-
tion with respect to the control, comparing the results under the cross-sectional
(CS), complete case (CC), ignorable (MAR), benchmark nonignorable (∆ = 0)
and the three alternative nonignorable departure scenarios. We specifically rely on
the examination of the Cost-Effectiveness Plane (CEP; Black, 1990) and the Cost-
Effectiveness Acceptability Curve (CEAC; Van Hout et al., 1994) to summarise the
economic analysis.
FIGURE 3 HERE
The CEP (Figure 3, panel a) is a graphical representation of the joint distribution
for the population average effectiveness and costs increments between the two arms,
indicated respectively as µe2 − µe1 and µc2 − µc1. We show the results only under
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three scenarios (light blue for CC, light green for MAR and light red for ∆flat) for
clarity and visualisation purposes. The results for the other nonignorable scenarios
are available in the Web Appendix. The slope of the straight line crossing the plane
is the “willingness to pay” threshold (often indicated as k). This can be considered
as the amount of budget the decision-maker is willing to spend to increase the health
outcome of one unit and effectively is used to trade clinical benefits for money. Points
lying below this straight line fall in the so-called sustainability area (Baio, 2012) and
suggest that the active intervention is more cost-effective than the control. In the
graph, we also show the Incremental Cost-Effectiveness Ratio (ICER) computed
under each scenario, as darker coloured dots. This is defined as
ICER =
E[µc2 − µc1]
E[µe2 − µe1]
and quantifies the cost per incremental unit of effectiveness. For all three scenarios
almost all samples fall in the North-East quadrant and are associated with positive
ICERs. This suggests that the intervention is likely to produce both QALY gains
and cost savings. The ICER under ∆flat falls in the sustainability area and indicates
a more positive cost-effective assessment for the new intervention compared with CC
and MAR.
The CEAC (Figure 3, panel b) is obtained by computing the proportion of
points lying in the sustainability area upon varying the willingness to pay thresh-
old k. Based on standard practice in routine analyses, we consider a range for
k up to £40,000 per QALY gained. The CEAC estimates the probability of cost-
effectiveness, thus providing a simple summary of the uncertainty associated with the
“optimal” decision-making suggested by the ICER. The results under CC and MAR
are reported using blue and green solid lines, respectively. In addition, the results
derived under nonignorability are reported using different coloured dashed lines.
The CEACs under CC, MAR and the benchmark scenarios show a similar trend
and indicate a probability of cost-effectiveness below 0.65 of the new intervention
for values of k up to £40, 000. However, under the other scenarios, the curve is
shifted upwards by an average probability of 0.2 (∆flat), 0.15 (∆skew0) and 0.25
(∆skew1) and suggests a more favourable cost-effectiveness assessment. The CEAC
plot shows that results are sensitive to the assumptions about the missing values,
which can lead to a considerable change in the output of the decision process and
the cost-effectiveness conclusions.
We finally compare the economic results under our longitudinal approach with
respect to those derived from a typical cross-sectional model (CS). Figure 4 shows
the CEPs (panel a) associated with the CS, CC and MAR scenarios, respectively
indicated with red, blue and green coloured dots. In the CEACs (panel b), in
addition to the probability values associated with these scenarios (solid lines), the
results from ∆flat are indicated with a dashed line.
FIGURE 4 HERE
The distribution of the posterior samples in the CEP (Figure 4, panel a) show some
differences between the scenarios with the ICER; CS is the lowest among those
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compared. In the CEAC (Figure 4, panel b), the acceptability curve for CS is
higher than those for CC and MAR for most willingness to pay values but remains
systematically lower with respect to the ∆flat, ∆skew0 and ∆skew1 (in Figure 4 we
only show the results for ∆flat for clarity).
7. Discussion
Missingness represents a threat to economic evaluations as, when dealing with
partially-observed data, any analysis makes assumptions about the missing values
that cannot be verified from the data at hand. Trial-based analyses are typically
conducted on cross-sectional quantities, e.g. QALYs and total costs, which are de-
rived based only on the observed data from the completers in the study. This is an
inefficient and likely biased approach, unless the completers are a random sample
of all study participants, because data from any partially-observed subject is lost.
A further concern is that routine analyses typically rely on standard models that
ignore or at best fail to properly account for potentially important features in the
data such as correlation, skewness, and the presence of structural values.
In this paper, we have proposed an alternative approach for conducting paramet-
ric Bayesian inference under nonignorable missingness for a longitudinal bivariate
outcome in health economic evaluations, while accounting for typical data features
such as skewness and presence of structural values in both utilities and costs. The
analysis of the PBS data shows the benefits of using our approach compared with a
standard cross-sectional model and a considerable impact of alternative MNAR as-
sumptions on the final decision-making conclusions, suggesting a more cost-effective
intervention compared with the results obtained under ignorability (MAR).
We relied on the extrapolation factorisation, within a pattern mixture approach,
and handled the sparsity of the data in most patterns by collapsing the non-completers
together when fitting the model. We identified the extrapolation distribution only
up to the marginal mean with partial identifying restrictions using the marginal
means estimated from the incompleters. As an alternative approach, we could have
used the marginal mean estimates from the completers, but we considered those of
the incompleters as a more reasonable default MNAR assumption. Next, we used
sensitivity parameters to characterise the uncertainty about the missing data within
each pattern. Alternative prior choices, calibrated in different ways using the ob-
served data, were chosen for the sensitivity parameters and the robustness of the
results across these scenarios was assessed.
An area for future work is to increase the flexibility of our approach through
a semi-parametric specification for the observed data distribution, which would al-
low a weakening of the model assumptions and likely further improve the fit of
the model to the observed data. As for the extrapolation distribution, alternative
identifying restrictions that introduce the sensitivity parameters via the conditional
mean (rather than the marginal mean) could be considered, and their impact on the
conclusions assessed in sensitivity analysis.
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Table 1. Missingness patterns for the outcome yj = (uj , cj) in the PBS study. For each pattern
and treatment group, the number of subjects (nrt) and the observed mean responses at each
time j = 0, 1, 2 are reported. We denote the absence of response values or individuals within
each pattern with –.
control (t = 1) intervention (t = 2)
u0 c0 u1 c1 u2 c2 nr1 u0 c0 u1 c1 u2 c2 nr2
r = 1 1 1 1 1 1 1 108 1 1 1 1 1 1 96mean 0.678 1546 0.684 1527 0.680 1520 0.726 2818 0.771 2833 0.759 2878
r 0 1 1 1 1 1 7 0 1 1 1 1 1 5mean – 1310 0.704 1440 0.644 1858 – 2573 0.780 2939 0.849 2113
r 1 1 0 1 1 1 4 1 1 0 1 1 1 1mean 0.709 1620 – 1087 0.737 851 0.467 9649 – 4828 0.259 4930
r 1 1 1 1 0 1 2 1 1 1 1 0 1 1mean 0.564 640 0.648 512 – 286 0.817 3788 0.884 0 – 0
r 1 1 0 0 1 1 4 1 1 0 0 1 1 1mean 0.716 2834 – – 0.634 679 0.501 3608 – – 0.872 4781
r 1 1 0 0 0 0 4 1 1 0 0 0 0 4mean 0.434 1528 – – – – 0.760 3086 – – – –
r 0 1 0 1 1 1 2 0 1 0 1 1 1 0mean – 595 – 397 0.483 69 – – – – – –
r 1 1 1 1 0 0 2 1 1 1 1 0 0 0mean 0.743 1434 0.705 1606 – – – – – – – –
r 1 1 0 1 0 1 3 1 1 0 1 0 1 0mean 0.726 1510 – 432 – 976 – – – – – –
Table 2. DIC and pD based on the observed
data likelihood for each variable in the model.
Two models are assessed either assuming Log-
Normal or Gamma distributions for the cost vari-
ables (lower DIC values shown in italics). Total
DIC and pD are also reported at the bottom of
the table.
Gamma LogNormal
variable DIC pD DIC pD
c0 2147.91 2.05 2133.39 1.97
u0 | c0 -377.52 2.87 -377.62 2.82
c1 | c0, u0 1904.53 4.16 1827.45 4.13
u1 | u0, c1 -468.02 5.37 -468.19 5.32
c2 | c1, u1 1913.69 4.65 1856.23 4.36
u2 | u1, c2 -454.07 5.87 -453.47 5.99
Total 4667 25 4518 25
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(a) control
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(b) intervention
Fig. 1. Posterior predictive distributions for the pairwise correlation between utilities and
costs variables in the control (panel a) and intervention (panel b) arm across 1000 ob-
served replicated datasets (light blue bars) compared with the estimates based on the
observed data in the real dataset (vertical blue lines).
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Fig. 2. Posterior means and 95% HPD intervals for the marginal utility and cost means in
the control (red dots and lines) and intervention (blue dots and lines) group at each time
j in the study across alternative assumptions. Six scenarios are compared: completers
(CC), ignorability (MAR), and nonignorability using the extrapolation factorisation under the
benchmark assumption (∆ = 0) and under the three scenarios described in Section 5.3
(∆flat,∆skew0,∆skew1). Since the baseline costs are fully observed in both groups, only the
results under CC and MAR are displayed for µc0.
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Table 3. Posterior means and 95% HPD credible intervals for µet and µct in the control
(t = 1) and intervention (t = 2) group under alternative scenarios: Cross-Sectional (CS),
CC, MAR, ∆ = 0, ∆flat,∆skew0 and ∆skew1
Scenario µe1 µe2 µc1 µc2
mean 95% CI mean 95% CI mean 95% CI mean 95% CI
CS 0.487 (0.452; 0.524) 0.611 (0.570; 0.651) 3073 (2188; 3915) 5768 (5115; 6413)
CC 0.672 (0.653; 0.691) 0.741 (0.720; 0.762) 3382 (2583; 4246) 6031 (5281; 6889)
MAR 0.662 (0.645; 0.681) 0.741 (0.721; 0.760) 3125 (2483; 3846) 6018 (5314; 6806)
∆ = 0 0.662 (0.641; 0.682) 0.742 (0.721; 0.763) 3233 (2489; 4041) 6208 (5364; 7142)
∆flat 0.635 (0.601; 0.666) 0.730 (0.707; 0.753) 3400 (2616; 4196) 6318 (5462; 7271)
∆skew0 0.644 (0.615; 0.672) 0.734 (0.712; 0.756) 3345 (2605; 4173) 6281 (5409; 7200)
∆skew1 0.626 (0.594; 0.656) 0.727 (0.703; 0.749) 3457 (2678; 4250) 6355 (5522; 7332)
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Fig. 3. CEPs (panel a) and CEACs (panel b) associated with alternative missingness
scenarios. In the CEPs, the ICERs based on the results from the complete cases (CC),
MAR and ∆flat are indicated with corresponding darker coloured dots, while the portion of
the plane on the right-hand side of the straight line passing through the plot (evaluated at
k = £25, 000) denotes the sustainability area. For the CEACs, in addition to the results
under CC and MAR (solid lines), the probability values for the alternative scenarios are
represented with different coloured dashed lines.
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Fig. 4. CEPs (panel a) and CEACs (panel b) associated with alternative scenarios. In
the CEPs, the ICERs based on the results from the cross-sectional model (CS), complete
cases (CC) and MAR are indicated with corresponding darker coloured dots, while the
portion of the plane on the right-hand side of the straight line passing through the plot
(evaluated at k = £25, 000) denotes the sustainability area. For the CEACs, in addition
to the results under CS, CC and MAR (solid lines), the probability values for ∆flat are
represented with a dashed line.
